The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals

Rachel Bayley, Kerry A. Kite, Helen M. McGettrick, Jacqueline P. Smith, George D. Kitas, Christopher D. Buckley, Stephen P. Young

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Objectives: A genetic variant of the leukocyte phosphatase PTPN22 (R620W) is strongly associated with autoimmune diseases including rheumatoid arthritis (RA). Functional studies on the variant have focussed on lymphocytes, but it is most highly expressed in neutrophils. We have investigated the effects of the variant on neutrophil function in health and in patients with RA. Methods: Healthy individuals and patients with RA were genotyped for PTPN22 (R620W) and neutrophils isolated from peripheral blood. Neutrophil adhesion and migration across inflamed endothelium were measured. Calcium (Ca2+) release and reactive oxygen species (ROS) production in response to fMLP stimulation were also assessed. Results: Expression of R620W enhanced neutrophil migration through cytokine activated endothelium (non-R620W=24%, R620W=45% migrating cells, p
    Original languageEnglish
    JournalAnnals of the rheumatic diseases
    DOIs
    Publication statusPublished - 24 Mar 2014

    Keywords

    • Autoimmune Diseases
    • Gene Polymorphism
    • Rheumatoid Arthritis

    Fingerprint

    Dive into the research topics of 'The autoimmune-associated genetic variant PTPN22 R620W enhances neutrophil activation and function in patients with rheumatoid arthritis and healthy individuals'. Together they form a unique fingerprint.

    Cite this